Anti-Myeloperoxidase antibody
4
(3 Reviews)
|
(33 Publications)
Rabbit Polyclonal Myeloperoxidase antibody. Suitable for WB, IHC-P and reacts with Rat, Mouse, Human samples. Cited in 33 publications. Immunogen corresponding to Synthetic Peptide within Human MPO.
View Alternative Names
Myeloperoxidase, MPO
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myeloperoxidase antibody (AB65871)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Myeloperoxidase using ab65871.
Myeloperoxidase was detected in paraffin-embedded section of human colon tissues. Heat mediated antigen retrieval was performed in citrate buffer (pH6, epitope retrieval solution) for 20 mins. The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/mL overnight at 4°C. Cy3 Conjugated Goat Anti-Rabbit IgG was used as secondary antibody at 1 : 100 dilution and incubated for 30 minutes at 37°C. The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myeloperoxidase antibody (AB65871)
This image shows human ovary tissue stained with ab65871 at 1µg/ml.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myeloperoxidase antibody (AB65871)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Myeloperoxidase using ab65871.
Myeloperoxidase was detected in paraffin-embedded section of human liver cancer tissues. Heat mediated antigen retrieval was performed in citrate buffer (pH6, epitope retrieval solution) for 20 mins. The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/ml ab65871 overnight at 4°C. Biotinylated goat anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using Strepavidin-Biotin-Complex with DAB as the chromogen.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myeloperoxidase antibody (AB65871)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Myeloperoxidase using ab65871.
Myeloperoxidase was detected in paraffin-embedded section of human tonsil tissues. Heat mediated antigen retrieval was performed in citrate buffer (pH6, epitope retrieval solution ) for 20 mins. The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/mL ab65871 overnight at 4°C. Cy3 Conjugated Goat Anti-Rabbit IgG was used as secondary antibody at 1 : 100 dilution and incubated for 30 minutes at 37°C. The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myeloperoxidase antibody (AB65871)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Myeloperoxidase using ab65871.
Myeloperoxidase was detected in paraffin-embedded section of mouse spleen tissues. Heat mediated antigen retrieval was performed in citrate buffer (pH6, epitope retrieval solution ) for 20 mins. The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/mL ab65871 overnight at 4°C. Cy3 Conjugated Goat Anti-Rabbit IgG was used as secondary antibody at 1 : 100 dilution and incubated for 30 minutes at 37°C. The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myeloperoxidase antibody (AB65871)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Myeloperoxidase using ab65871.
Myeloperoxidase was detected in paraffin-embedded section of rat colon tissues. Heat mediated antigen retrieval was performed in citrate buffer (pH6, epitope retrieval solution ) for 20 mins. The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/mL ab65871 overnight at 4°C. Cy3 Conjugated Goat Anti-Rabbit IgG was used as secondary antibody at 1 : 100 dilution and incubated for 30 minutes at 37°C. The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
- WB
Unknown
Western blot - Anti-Myeloperoxidase antibody (AB65871)
All lanes:
Western blot - Anti-Myeloperoxidase antibody (ab65871) at 2 µg/mL
All lanes:
rat brain tissue lysate
Predicted band size: 83 kDa
Observed band size: 170 kDa
false
- WB
CiteAb
Western blot - Anti-Myeloperoxidase antibody (AB65871)
Myeloperoxidase western blot using anti-Myeloperoxidase antibody ab65871. Publication image and figure legend from Horinokita, I., Hayashi, H., et al., 2019, Int J Mol Sci, PubMed 31640144.
ab65871 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab65871 please see the product overview.
(A) Changes in tissue elastase activity in the vehicle-treated (-) sham and ME groups and sivelestat-treated (+) sham and ME groups on day 1 after surgery. * Significant difference from the vehicle-treated sham group (p < 0.05).
Significant difference from the vehicle-treated ME group (p < 0.05). Each value represents the mean ± SD of 6
animals; (B) Levels of myeloperoxidase (MPO) protein in the vehicle-treated (-) sham and ME groups and sivelestat-treated (+) sham and ME groups on day 1 after surgery. Bands corresponding to MPO were scanned, and the scanned band was normalized by β-actin on the same blot. The results are expressed as the mean ratio of the non-operated (control) group ± SD (n = 8 each). * Significant difference from the sham group (p < 0.05); (C) Images of double staining (merge, c, f, i, and l) with Hoechst 33342 (blue, a, d, g, and j) and MPO (green, b, e, h, and k) for the vehicle-treated sham and ME groups and sivelestat-treated sham and ME groups on day 1 after surgery. The scale bar represents 100 μm; (D) The number of MPO-positive cells in the vehicle-treated (-) sham and ME groups and sivelestat-treated (+) sham and ME groups on day 1 after surgery was counted. Five sections were made per animal, and 266–722 cells were counted per section, and the average of 5 sections per animal was calculated. The values for MPO-positive cells are presented as the mean ± SD (n = 5 each). * Significant difference from the sham group (p < 0.05).
false
Reactivity data
Properties and storage information
Form
Reconstitution
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The generation of reactive oxygen species by myeloperoxidase is essential for microbicidal activity. Myeloperoxidase functions as part of the antimicrobial system in the phagosome which is the intracellular compartment where pathogens are degraded. This enzyme works in conjunction with other components of the immune system such as NADPH oxidase. By generating hypochlorous acid MPO contributes to the oxidative burst a rapid release of reactive oxygen species during the response to pathogens.
Pathways
Myeloperoxidase integrates into the immune defense and inflammatory pathways. In particular it is associated with the neutrophil degranulation pathway where it releases its enzymatic contents to fight off microbes. MPO also interacts with proteins involved in oxidative stress processes such as superoxide dismutase which moderates levels of reactive oxygen species in cells. These interactions ensure balance in the immune response preventing excessive tissue damage during inflammation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (33)
Recent publications for all applications. Explore the full list and refine your search
Physiological reports 13:e70558 PubMed40970288
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 222: PubMed40663042
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 14: PubMed39791727
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 24:1336 PubMed39487474
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 13: PubMed37627304
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmacologica Sinica 44:2184-2200 PubMed37328648
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 220: PubMed37261457
2023
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2205059 PubMed36755334
2023
Applications
Unspecified application
Species
Unspecified reactive species
Asian journal of pharmaceutical sciences 18:100782 PubMed36845839
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:1396 PubMed36697446
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com